BAVENCIO® (avelumab) is an immunotherapy—a medicine that may help your immune system fight metastatic Merkel cell carcinoma




BAVENCIO is a prescription medicine used to treat a type of skin cancer called Merkel cell carcinoma (MCC) in adults and children 12 years of age and older. BAVENCIO may be used when your skin cancer has spread. This indication is approved under accelerated approval based on a clinical trial that measured how many patients responded and how long they responded. Continued approval may depend on benefit demonstrated in ongoing clinical trials. It is not known if BAVENCIO is safe and effective in children under the age of 12.